The largest database of trusted experimental protocols

Anti cd16 32

Manufactured by BioXCell
Sourced in United States

Anti-CD16/32 is a laboratory reagent that can be used to block the CD16 and CD32 receptors on cells. It is often used in flow cytometry and cell-based assays to prevent non-specific binding of antibodies or other ligands to these Fc receptors.

Automatically generated - may contain errors

9 protocols using anti cd16 32

1

Multiparametric flow cytometry analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were incubated with anti-CD16/32 (BioXcell) for 15 min at 4 °C, followed by staining with fluorescently conjugated antibodies for 30–45 min at 4 °C.
The following cell populations were identified based on cell marker expression: neutrophils (CD45+CD11b+Ly6CLy6G+), monocytes (CD45+ CD11b+Ly-6GLy-6Chigh), CD11b+ macrophage (CD45+CD11b+Ly6GLy6CF4/80+), T cells (CD45+CD3+CD4+ or CD8+), B cells (CD45+B220+CD19+), NK cells (CD45+CD3NK1.1+), DC1 (CD45+CD3CD19NK1.1, MHCII+CD11c+ CD64CD11bCD103+ (tumour) XCR1+ (lymphoid tissue)), DC2 (CD45+ CD3CD19NK1.1MHCII+CD11c+CD64CD11b+CD103/XCR1), migDC DC1 (CD45+CD3CD19NK1.1MHCII+CD11c+CD64CD11b+CD103+).
The following antibodies (Biolegend and BD) were used: CD45 (30-F11), CD4 (RM4-5), CD8a (53-6.7), B220 (RA3-6B2), NK1.1 (PK136), CD11b (M1/70), CD11c (N418), CD103 (P84), XCR1 (ZET), CD64 (X54-5/7.1), CD86 (GL-1), PDL1 (10F.9G2), CD27 (LG.3A10), IL-7Ra (A7R34), CXCR5 (L138D7), CX3CR1 (SA011F11), CD5 (53-7.3), CD24 (M1/69), PDL2 (122), Lag3 (C9B7W), TIGIT (GIGD7), TIM-3 (5D12), Ly6C (HK1.4), Ly6G (1A8), TCRb (H57-597), F4/80 (BM8), Ki67 (16A8), T-bet (4B10) and TCF1 (C63D9).
+ Open protocol
+ Expand
2

Flow Cytometric Immunophenotyping of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspension was stained with anti-CD16/32 (BioXcell, 1 mg ml1, 1:100) and conjugated antibodies against any combination of the following surface antigens: CD4 (RM4.5, 1:400), CD8 (53-6.7, 1:400), CD45 (30-F11, 1:400), TCRβ (H57-597, 1:200) and PD-1 (29F.1A12, 1:200). For examination of cytokines and cellular proliferation, conjugated antibodies against any combination of the following intracellular antigens were used: TNF (MP6-X122, 1:200), IFNγ (XMG1.2, 1:200) and Ki-67(16A8, 1:1,000).
+ Open protocol
+ Expand
3

Immunostaining of Testicular Frozen Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunostaining using frozen sections, testes were embedded in optimum cutting temperature compound (O.C.T.) and frozen in liquid nitrogen. Serial sections were cut at 5 μM thickness onto glass slides and stored at −80°C until use. Slides were blocked 1 h at room temperature in PBS/5% BSA/1% mouse serum/1% anti-CD16/32 (BioXcell; clone 2.4G2). Primary and secondary antibodies were added, followed by staining with DAPI. The following antibodies were used throughout this study: anti-F4/80-AlexaFluor647 (BioLegend; clone BM8), CD3ϵ (Santa Cruz Biotechnology; clone M-20), SOX9 (abcam; clone EPR14335-78), Biotin-SP-conjugated Affinipure Donkey Anti-Goat IgG (H+L) (Jackson immunoresearch; code:705-065-147), Cy™3 conjugated Sreptavidin (Jackson immunoresearch; code:016-160-084), Cy™3 AffiniPure Donkey Anti-Rabbit IgG (H+L) (Jackson immunoresearch; code: 711-165-152).
+ Open protocol
+ Expand
4

Ex vivo CD45+ Cell Coupling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ex vivo coupling assays were performed as described previously (Broz et al., 2014 (link)). Briefly, single cells suspensions were enriched for CD45+ cells using EasySep biotin positive selection kit (Stemcell Technologies). Enriched cells were stained with with Zombie NIR Fixable live/dead dye (Biolegend) for 20 min at 4°C, followed by staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing anti-CD16/32 (BioXCell) to block non-specific binding. Cells were washed again and co-cultured with VPD-labeled previously activated OT-I CD8+ T cells for 1 hour at 37°C. Cells were lightly fixed in 2% PFA followed by read-out on a BD LSR Fortessa SORP cytometer.
+ Open protocol
+ Expand
5

Bone Marrow-Derived Macrophage Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were stained for viability using the Zombie Aqua Fixable dye (BioLegend), followed by Fc blocking using 20 µg/mL anti-CD16/32 (BioxCell, clone 2.4G2) for 20 min. Cells were stained with BV421-conjugated anti-CD64 (BioLegend, clone X54–5/7.1) and acquired on a BD LSRII. Data were analyzed using FlowJo v10 (BD Biosciences).
+ Open protocol
+ Expand
6

Isolation and Sorting of Tumor-Infiltrating Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions from tumors were prepared as described above. For T cell isolations, single cell suspensions were enriched for mononuclear cells using Ficoll-Paque Premium 1.084 (GE Healthcare). For isolation of myeloid cells, single cell tumor suspensions were enriched for CD45+ cells using EasySep biotin positive selection kit (Stemcell Technologies). Enriched cells were stained for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing anti-CD16/32 (BioXCell) to block non-specific binding. Cells were washed again with FACS buffer and filtered over a 70μm mesh. Immediately prior to sorting, DAPI was added to exclude dead cells. Cells were sorted on a BD FACSAria Fusion and BD FACSAria2. Sorted T cells were collected directly in lysis buffer (Invitrogen) for RNA sequencing or in RPMI (GIBCO), 10% FCS (Benchmark), Pen/Strep/Glut (Invitrogen) and 50μM β-mercaptoethanol (GIBCO) at 4°C for further use ex vivo. Sorted myeloid cells were collected in DMEM (GIBCO), 10% FCS (Benchmark), Pen/Strep/Glut (Invitrogen) at 4°C for further use ex vivo.
+ Open protocol
+ Expand
7

Hypoxia Mapping in Murine Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected with pimonidazole hydrochloride in PBS (80mg/kg; Hypoxyprobe) intraperitoneally 1.5 hours prior to sacrifice. Tissues were dissected and processed as described above. For flow cytometry studies, pimonidazole was visualized using anti-pimonidazole antibodies (Pacific Blue Mab-1 clone 4.3.11.3; Hypoxyprobe) after cells were fixed for 20 min at 4°C using the FOXP3 Fix/Perm kit (BD Biosciences), and washed in permeabilization buffer. For imaging studies, dissected tumors were embedded in OCT and sectioned into 10μm cryosections. Cryosections were stored at −80°C until further use. For immunostaining, sections were fixed in 4% PFA (Electron Microscopy Sciences) for 20 minutes at RT, followed by a rinse in PBS containing 1% BSA (Sigma). Sections were blocked in 1% BSA in PBS containing anti-CD16/32 (BioXCell) for 1 hour at RT, and washed. Sections were stained with CD11b-AF594 (clone M1/70;BioLegend), CD31-AF647 (clone 390;BioLegend) and Pacific Blue Mab-1 (clone 4.3.11.3;Hypoxyprobe) for 1 hour at RT, followed by a wash and mounted using Vectashield (Vector Laboratories) and sealed with nail polish. Images were acquired on a Leica SP8 confocal microscope. Data analysis was performed using Imaris (Bitplane).
+ Open protocol
+ Expand
8

Purification and Labeling of OTI CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
OTI cells were purified from the spleens of CD45.1+ OTI mice by incubating single cell suspensions with anti-CD16/32 (BioXcell) and anti–CD8 magnetic beads (Miltenyi Biotec), for 45 minutes at 4°C. After washing, CD8+ cells were enriched by magnetic separation using LS–columns (Miltenyi Biotec) and stained with cell trace violet (CTV, Thermo–Fisher) according to instructions. Cells were adjusted to 6 x 105 cells/mL in sterile PBS and 50 μL of the cell suspension were transferred intraperitoneally. For DC enrichment, cell suspensions from dissociated lungs were incubated with anti–CD11c magnetic beads followed by magnetic separation using LS columns (Miltenyi Biotec). After enrichment, DCs were purified by first gating on LinCD64MHCII+CD11c+ cells and sorted based on expression of CD103, CD11b, SIRPα. Post–sorting purity was >95%. All sorting was performed using a FACSAriaII provided by the Flow Cytometry and Single Cell services Core at UAB.
+ Open protocol
+ Expand
9

Murine Immune Cell Profiling for Malaria

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male BALB/c mice (6–8 weeks old) used for this study were maintained under pathogen-free condition at institutional animal house facility. Anti-mouse antibodies Alexa Fluor 700-CD8 (Clone 53-6.7), APC-cy7-CD19 (Clone 1D3), APC-cy7-CD45R/B220 (Clone RA3-6B2), were procured from BD Biosciences (San Jose, CA, USA), FITC-CD4 (clone GK 1.5), FITC CD278 (7E.17G9), APC-CD278 (Clone-C398.4A), PerCP-Cy 5.5-CD4 (clone RM4-5), PE-Cy7-IFN-γ (clone XMG 1.2), PE-T-bet (clone eBio 4B10), Alexa Fluor 700-CD8 (53-6.7) were from eBioscience (San Diego, CA, USA), Brilliant violet 605 TCR Vb (clone H57-597), APC-CD278 (clone C398.4A), Anti-CD49b (clone DX5) were from BioLegend (San Diego, CA, USA). Purified antibodies Anti-mouse CD278 ICOS (clone 7E.17G9), Anti-Rat IgG2b isotype control, and anti-CD16/32 were procured from BioXcell (West Lebanon, USA). Dynabeads untouched mouse CD4+ T cell isolation kit was procured from Life Technologies AS (Oslo, Norway) and CD8+ T cell negative selection kit was from Stem cell technologies (Vancouver, BC, Canada). Phorbol 12-myristate 13-acetate (PMA), Ionomycin, Brefeldin A was procured from Sigma-Aldrich (St. Louis, MO, USA). Malarial parasite P. berghei ANKA (MRA-671, MR4, ATCC, Manassas, VA, USA) was obtained from MR4 repository, ATCC, Manassas, VA, USA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!